Micro-Dosed Lithium for Brain Health and Longevity

TL;DR: Micro-dose lithium is one of the most controversial longevity supplements. Large population studies suggest that tiny amounts of lithium in drinking water correlate with lower dementia and suicide rates. However, no randomised human trial has proven brain protection, and lithium can harm kidneys and thyroid even at low doses. This guide explains the evidence and the risks honestly.

1. What Is Micro-Dosed Lithium?

Lithium is a naturally occurring alkali metal found in drinking water in trace amounts. Psychiatric doses for bipolar disorder are typically 150–2,000 mg/day of elemental lithium, producing blood levels of 0.6–1.0 mmol/L. "Micro-dose" lithium usually means less than 1 mg/day of elemental lithium, often 0.3–0.5 mg/day, sold as lithium orotate, citrate or aspartate.

The longevity hypothesis is simple: if trace environmental lithium is associated with better mental-health and cognitive outcomes, then tiny supplemental doses might provide similar benefits with minimal risk.

2. Trace-Lithium Epidemiology: Dementia and Suicide

The most cited evidence comes from ecological and observational studies comparing regions with different natural lithium levels in tap water:

• Eyre-Watt et al., 2021: A systematic review and meta-analysis across 2,678 regions containing 113 million people found that higher lithium in drinking water was associated with lower suicide rates and some better neuropsychiatric outcomes, though dementia findings were more mixed (doi:10.1177/0004867420963740).
• Da Porto et al., 2024: A systematic review in International Journal of Bipolar Disorders concluded that higher trace lithium exposure was associated with reduced dementia risk in most studies, but the evidence quality was low to moderate.
• Terao & Hirakawa, 2024: A qualitative review summarised the case for trace lithium in suicide and dementia prevention, while calling for randomised trials.

3. Human Trials: What Is Missing

As of 2026, high-quality randomised controlled trials of micro-dose lithium for dementia prevention in the general population are scarce:

• Small pilot studies: some have shown slowing of cognitive decline in people with mild cognitive impairment (MCI) at micro-doses, but results are inconsistent.
• Larger trials are ongoing: several groups are testing low-dose lithium in MCI and Alzheimer's disease, but no definitive results are available.
• No lifespan trial: no study has tested whether micro-dose lithium extends life.

The current evidence is promising enough to justify research, but not strong enough to recommend routine supplementation for healthy adults.

4. Proposed Mechanisms

Why might tiny amounts of lithium affect brain ageing? Several mechanisms have been proposed:

• GSK-3β inhibition: lithium inhibits glycogen synthase kinase-3β, an enzyme involved in tau pathology and amyloid processing.
• Neuroprotection: animal studies show increased brain-derived neurotrophic factor (BDNF) and reduced neuroinflammation.
• Anti-suicide effects: lithium may stabilise mood and impulsivity even at trace exposures.
• Anti-inflammatory: low-dose lithium may dampen microglial activation.

Most of this evidence comes from cell and animal studies, not confirmed human trials.

5. Dose and Product Forms in the UK

Note: supplement labels may list the weight of the salt, not the elemental lithium. Lithium orotate is roughly 4% elemental lithium by weight.

6. Safety: The Most Important Section

Lithium has a narrow therapeutic window. Even micro-doses are not risk-free:

• Kidney function: lithium can cause nephrogenic diabetes insipidus and chronic kidney disease over time, even at low doses.
• Thyroid: lithium can cause hypothyroidism and hyperparathyroidism.
• Drug interactions: lithium interacts with diuretics, ACE inhibitors, ARBs, NSAIDs and dehydration.
• Pregnancy: lithium is teratogenic at psychiatric doses; micro-dose safety is unknown. Avoid unless specifically advised.

7. Who Might Consider It (and Who Should Not)

Consider only after medical consultation if:

• You have a strong family history of dementia and are otherwise healthy.
• You are enrolled in a supervised clinical trial.

Avoid or seek specialist advice if:

• You have kidney or thyroid disease.
• You take diuretics, ACE inhibitors/ARBs, lithium, or NSAIDs regularly.
• You are pregnant, planning pregnancy or breastfeeding.
• You have a history of thyroid or parathyroid disorders.

8. Buying Lithium Supplements in the UK

Lithium orotate is available as a food supplement in the UK, but because of the safety profile we do not recommend self-selection. If a clinician agrees it is appropriate:

• Choose a brand that states the elemental lithium content clearly.
• Look for third-party testing and a UK-registered seller.
• Avoid products that make disease-treatment claims.

Look for third-party-tested UK products from sellers that publish certificates of analysis and have a UK-registered business address.

9. References

10. FAQ